Cargando…
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
Autores principales: | Yu, Albert, Dai, Xiaoyong, Wang, Zixian, Chen, Huaqing, Guo, Bing, Huang, Laiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599890/ https://www.ncbi.nlm.nih.gov/pubmed/36291049 http://dx.doi.org/10.3390/bios12100794 |
Ejemplares similares
-
Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
por: Yu, Albert, et al.
Publicado: (2022) -
Mesoporous silica/organosilica nanoparticles for cancer immunotherapy
por: Theivendran, Shevanuja, et al.
Publicado: (2023) -
Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021) -
Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy
por: Escriche‐Navarro, Blanca, et al.
Publicado: (2022) -
Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents
por: Chircov, Cristina, et al.
Publicado: (2020)